Microflora Disturbance during Progression of Glucose Intolerance and Effect of Sitagliptin: An Animal Study
Open accessThe DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Abstract
Background. Emerging evidences have shown a close interplay between obesity, diabetes, and intestinal flora disturbance. Dipeptidyl peptidase-4 inhibitor, exemplified by sitagliptin, is highly efficacious in treating type 2 diabetes (T2DM), yet little is known if sitagliptin exerts beneficial effects on microbiota associated with obesity and T2DM. We evaluated changes of gut microbiota following the induction of obesity and T2DM in a streptozotocin treated high fat/high carbohydrate fed (HF/HC-STZ) rat model and explored the effect of sitagliptin on gut microbiota for HF/HC-STZ rats.Methods. Sitagliptin was administered via oral gavage to diabetic rats. Fecal DNA extraction and 454 pyrosequencing based on analysis of 16S rRNA genes was utilized to determine the overall structure of microbiota in fecal DNA samples.Results. Results showed that, at the level of phylum, there was higher abundance of Firmicutes and Tenericutes and less abundance of Bacteroidetes in obese rats compared to their lean counterparts. At the level of genus, short-chain fatty acid- (SCFA-) producing bacteria,Blautia,Roseburia, and Clostridium, and probiotics Lactobacillus,Bifidobacterium, and so forth were identified significantly different from each other among conditions.Conclusion. Marked shifts of the gut microbiota structure were observed in the rats during development of glucose intolerance. Intestinal flora changed in the process of glucose intolerance, and treatment of sitagliptin moderately corrected the dysbiosis of microbiota in T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, DPP-4 inhibitors are also able to modify gut microbiota by increasing Firmicutes and Tenericutes phyla and decreasing Bacteroidetes in DIO rodents [307].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [307]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gut Microbiota Is a Key Modulator of Insulin Resistance in TLR 2 Knockout Mice
Caricilli, A. M., Picardi, P. K., de Abreu, L. L., Ueno, M., Prada, P. O., Ropelle, E. R., Hirabara, S. M., Castoldi, Â., Vieira, P., Camara, N. O. S., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001212 · Cited by 282 · cited 1×
“The associations between microbiota and obesity, insulin resistance, and diabetes are presumably due to the impaired ability of the microbes to extract energy from the diet [9], altered fatty acid metabolism [11], changes in secretion of gut hormones such as peptide YY (PYY) [12], activation of lipopolysaccharide toll…”
BackgroundRetractedSchloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 1×
“Implantation of gut flora from obese mice to normal and germfree mice resulted in increased body weight and insulin resistance [9, 10] supporting the notion that the bacterial species from obese gut have metabolically unfavorable properties.”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 1×
“SCFA-producing bacteria have been previously shown to benefit the host through protecting the mucosa from damage induced by pathogens, supplying colonocyte nutrients, mitigating inflammation, and so forth [39, 40].”
BackgroundMetagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699 · cited 1×
“Among available methodologies to study the microbial ecology of complex bacterial communities, the so-called metagenomics approach is considered to be the “golden standard” [18, 19].”
BackgroundRegulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Turnbaugh, P. J., Bäckhed, F., Fulton, L., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.015 · Cited by 2,915
Colonic Health: Fermentation and Short Chain Fatty Acids
Wong, J. M. W., de Souza, R., Kendall, C. W. C., Emam, A., & Jenkins, D. J. A. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200603000-00015 · Cited by 2,739 · cited 1×
“It is noteworthy that about one-third of the species only found in normal (64OTUs) or obesity (22OTUs) condition belonged to Lachnospiraceae, which is capable of fermenting complex carbohydrates to SCFAs playing an important role in maintaining intestinal homeostasis [27, 28].”
BackgroundCani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 1×
“The associations between microbiota and obesity, insulin resistance, and diabetes are presumably due to the impaired ability of the microbes to extract energy from the diet [9], altered fatty acid metabolism [11], changes in secretion of gut hormones such as peptide YY (PYY) [12], activation of lipopolysaccharide toll…”
BackgroundMicrobial degradation of complex carbohydrates in the gut
Flint, H. J., Scott, K. P., Duncan, S. H., Louis, P., & Forano, E. (2012) · Gut Microbes · doi:10.4161/gmic.19897 · Cited by 2,331 · cited 1×
“Interestingly, one-third of the total species only found in sitagliptin condition (94OTUs) belonged to Ruminococcaceae, which is a major utilizer of plant polysaccharides [29, 30].”
BackgroundDisentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., et al. (2015) · Nature · doi:10.1038/nature15766 · Cited by 2,116
Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples
White, J. R., Nagarajan, N., & Pop, M. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000352 · Cited by 1,586 · cited 1×
“frequency data and false discovery rate (FDR) analysis using Metastat analysis [25].”
MethodShin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T. W., Lee, M.-S., & Bae, J.-W. (2014) · Gut · doi:10.1136/gutjnl-2012-303839 · Cited by 1,550
Comparative genomics of the lactic acid bacteria.
Makarova, K., Slesarev, A., Wolf, Y., Sorokin, A., Mirkin, B., Koonin, E., Pavlov, A., Pavlova, N., Karamychev, V., Polouchine, N., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607117103 · Cited by 1,391
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers
Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Jia, W., Cai, S., & Zhao, L. (2012) · The ISME Journal · doi:10.1038/ismej.2011.109 · Cited by 1,287
Habitat degradation impacts black howler monkey ( Alouatta pigra ) gastrointestinal microbiomes
Amato, K. R., Yeoman, C. J., Kent, A., Righini, N., Carbonero, F., Estrada, A., Rex Gaskins, H., Stumpf, R. M., Yildirim, S., Torralba, M., et al. (2013) · The ISME Journal · doi:10.1038/ismej.2013.16 · Cited by 1,238 · cited 1×
“edu/) against the SILVA (SSU115) 16S rDNA database using confidence threshold of 70% [22].”
MethodJumpertz, R., Le, D. S., Turnbaugh, P. J., Trinidad, C., Bogardus, C., Gordon, J. I., & Krakoff, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.010132 · Cited by 1,232 · cited 1×
“We found significantly more Firmicutes and less Bacteroidetes in obese rats compared to their lean counterparts, similar to previous studies [31] despite conflicting data showing no differences of Bacteroidetes and Firmicutes between obese and lean subjects [32–34].”
ResultHuman colonic microbiota associated with diet, obesity and weight loss
Duncan, S. H., Lobley, G. E., Holtrop, G., Ince, J., Johnstone, A. M., Louis, P., & Flint, H. J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.155 · Cited by 1,222 · cited 1×
“We found significantly more Firmicutes and less Bacteroidetes in obese rats compared to their lean counterparts, similar to previous studies [31] despite conflicting data showing no differences of Bacteroidetes and Firmicutes between obese and lean subjects [32–34].”
ResultDevelopmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells
Stappenbeck, T. S., Hooper, L. V., & Gordon, J. I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202604299 · Cited by 1,095
Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon
Ze, X., Duncan, S. H., Louis, P., & Flint, H. J. (2012) · The ISME Journal · doi:10.1038/ismej.2012.4 · Cited by 1,060 · cited 1×
“Interestingly, one-third of the total species only found in sitagliptin condition (94OTUs) belonged to Ruminococcaceae, which is a major utilizer of plant polysaccharides [29, 30].”
BackgroundObesity and the human microbiome
Ley, R. E. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328333d751 · Cited by 770 · cited 1×
“We found significantly more Firmicutes and less Bacteroidetes in obese rats compared to their lean counterparts, similar to previous studies [31] despite conflicting data showing no differences of Bacteroidetes and Firmicutes between obese and lean subjects [32–34].”
ResultNobaek, S., Johansson, M.-L., Molin, G., Ahrné, S., & Jeppsson, B. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02015.x · Cited by 653 · cited 1×
“Recent data also suggest that microflora, especially probiotics, exert beneficial effects on gastrointestinal discomforts such as diarrhea, abdominal pain, and bloating [44].”
BackgroundThe gut microbiota modulates host energy and lipid metabolism in mice
Velagapudi, V. R., Hezaveh, R., Reigstad, C. S., Gopalacharyulu, P., Yetukuri, L., Islam, S., Felin, J., Perkins, R., Borén, J., Orešič, M., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m002774 · Cited by 589 · cited 1×
“The associations between microbiota and obesity, insulin resistance, and diabetes are presumably due to the impaired ability of the microbes to extract energy from the diet [9], altered fatty acid metabolism [11], changes in secretion of gut hormones such as peptide YY (PYY) [12], activation of lipopolysaccharide toll…”
BackgroundEnhancing Incretin Action for the Treatment of Type 2 Diabetes
Drucker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2929 · Cited by 579 · cited 1×
“decrease glucagon secretion, decrease hepatic gluconeogenesis, improve insulin sensitivity, and delay gastric emptying [15].”
BackgroundThe Host Genotype Affects the Bacterial Community in the Human Gastronintestinal Tract
Erwin G. Zoetendal, A. D. L. A. (2001) · Microbial Ecology in Health and Disease · doi:10.1080/089106001750462669 · Cited by 553
Hold, G. L., Schwiertz, A., Aminov, R. I., Blaut, M., & Flint, H. J. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.7.4320-4324.2003 · Cited by 350 · cited 1×
“Fusobacterium prausnitzii and Roseburia intestinalis are predominant species in butyric acid producing bacteria in human and animal intestine [42].”
BackgroundHuman Colonic Microbiota: Ecology, Physiology and Metabolic Potential of Intestinal Bacteria
Macfarlane, G. T., & Macfarlane, S. (1997) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.1997.11720708 · Cited by 342 · cited 1×
“2 , acetic acid, and/or ethanol which may contribute to a more acidic environment through homo- or heterofermentative metabolism [45, 46].”
BackgroundPhysiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2
Drucker, D. J., & Yusta, B. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170317 · Cited by 342
Diamant, M., Blaak, E. E., & de Vos, W. M. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00797.x · Cited by 308
The role of the intestinal microflora for the development of the immune system in early childhood
Ouwehand, A., Isolauri, E., & Salminen, S. (2002) · European Journal of Nutrition · doi:10.1007/s00394-002-1105-4 · Cited by 264
Ahrén, B., Johnson, S. L., Stewart, M., Cirkel, D. T., Yang, F., Perry, C., & Feinglos, M. N. (2014) · Diabetes Care · doi:10.2337/dc14-0024 · Cited by 228
Discovering lactic acid bacteria by genomics
Klaenhammer, T. R., Altermann, E., Arigoni, F., Bolotin, A., Breidt, F., Broadbent, J., Cano, R. J., Chaillou, S., Deutscher, J., Gasson, M. J., et al. (2002) · Antonie van Leeuwenhoek · doi:10.1023/a:1020638309912 · Cited by 214
Discovering lactic acid bacteria by genomics
Klaenhammer, T., Altermann, E., Arigoni, F., Bolotin, A., Breidt, F., Broadbent, J., Cano, R., Chaillou, S., Deutscher, J., Gasson, M., et al. (2002) · Lactic Acid Bacteria: Genetics, Metabolism and Applications · doi:10.1007/978-94-017-2029-8_3 · Cited by 209
Bajzer, M., & Seeley, R. J. (2006) · Nature · doi:10.1038/4441009a · Cited by 196
Human intestinal microbiota: Characterization of a simplified and stable gnotobiotic rat model
Becker, N., Kunath, J., Loh, G., & Blaut, M. (2011) · Gut Microbes · doi:10.4161/gmic.2.1.14651 · Cited by 170 · cited 1×
“coli, indicating that either of these organisms competes with Clostridium butyricum for the same substrates or Clostridium butyricum forms inhibitory substances [43].”
BackgroundMai, V., McCrary, Q. M., Sinha, R., & Glei, M. (2009) · Nutrition Journal · doi:10.1186/1475-2891-8-49 · Cited by 170 · cited 1×
“We found significantly more Firmicutes and less Bacteroidetes in obese rats compared to their lean counterparts, similar to previous studies [31] despite conflicting data showing no differences of Bacteroidetes and Firmicutes between obese and lean subjects [32–34].”
ResultWronkowitz, N., Görgens, S. W., Romacho, T., Villalobos, L. A., Sánchez‐Ferrer, C. F., Peiró, C., Sell, H., & Eckel, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.004 · Cited by 159
The Family Lachnospiraceae, Including the Genera Butyrivibrio, Lachnospira and Roseburia
Cotta, M. A., & Forster, R. J. (2006) · Springer eBooks · doi:10.1007/0-387-30744-3_35 · Cited by 138
Modulation of Gut Microbiota in the Management of Metabolic Disorders: The Prospects and Challenges
Erejuwa, O., Sulaiman, S., & Wahab, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034158 · Cited by 136 · cited 1×
“The binding of SCFA to two G-protein-coupled receptors (GPR41 and GPR43) induces peptide YY secretion, which suppresses gut motility, retards intestinal transit, and subsequently results in the increase of nutrient uptake and deposition [35].”
BackgroundEsteve, E., Ricart, W., & Fernández-Real, J.-M. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328348c06d · Cited by 133
Glucagon-like peptides 1 and 2 in health and disease: A review
Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Peptides · doi:10.1016/j.peptides.2013.01.014 · Cited by 100 · cited 1×
“GLP-2 appears to be an intestinal specific growth factor, promoting the growth of intestinal mucosa, repairing damaged intestinal epithelium, and improving the intestinal mucosa barrier integrity [16, 17].”
BackgroundReasner, C., Olansky, L., Seck, T. L., Williams‐Herman, D. E., Chen, M., Terranella, L., Johnson‐Levonas, A. O., Kaufman, K. D., & Goldstein, B. J. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01390.x · Cited by 90
Regulation of Epithelial Cell Tight Junctions by Protease-Activated Receptor 2
Enjoji, S., Ohama, T., & Sato, K. (2014) · Journal of Veterinary Medical Science · doi:10.1292/jvms.14-0191 · Cited by 41
Min, L. (2003) · Acta Laboratorium Animalis Scientia Sinica · Cited by 4
An experimental study of impaired glucose tolerance in Wistar rats
Chun-hu, G. (2007) · Chinese Remedies & Clinics · Cited by 2
Research works printed but not linked: 5
- 2002, European Journal of Nutrition, 41, I32
- 2005, Acta Laboratorium Animals Scientia Sinica, 13, 154
- 2003, Acta Laboratorium Animals Scientia Sinica, 11, 138
- 2007, Chinese Remedies & Clinics, 7, 281
- 10.1016/s0002-9270(00)00807-8 · DOI · Paper page
Cited by
Hosomi, K., Saito, M., Park, J., Murakami, H., Shibata, N., Ando, M., Nagatake, T., Konishi, K., Ohno, H., Tanisawa, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32015-7 · Cited by 451
Drug-microbiota interactions: an emerging priority for precision medicine
Zhao, Q., Chen, Y., Huang, W., Zhou, H., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01619-w · Cited by 268
“387 Similarly, vildagliptin administration was related to increased Bacteroidetes and decreased Firmicutes coupled with decreased Firmicutes-to-Bacteroidetes ratio in diabetic rats.”
BackgroundXiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota
Wei, X., Tao, J., Xiao, S., Jiang, S., Shang, E., Zhu, Z., Qian, D., & Duan, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22094-2 · Cited by 256
Gut microbiota in the pathogenesis and therapeutic approaches of diabetes
Crudele, L., Gadaleta, R. M., Cariello, M., & Moschetta, A. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104821 · Cited by 251
Inulin-type fructan improves diabetic phenotype and gut microbiota profiles in rats
Zhang, Q., Yu, H., Xiao, X., Hu, L., Xin, F., & Yu, X. (2018) · PeerJ · doi:10.7717/peerj.4446 · Cited by 182
“Previous studies found that Lactobacillus decreased in diabetic rats (Yan et al., 2016) and HF rats (Lau et al., 2016).”
Result
Metadata
- Authors
- Yan, X., Feng, B., Li, P., Tang, Z., & Wang, L.
- Affiliations
- Tongji University (CN)
- Corresponding author
- Feng, Bo
- Venue
- Journal of Diabetes Research
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-10
- ISSN
- 2314-6745 (ISSN-L)
- 2314-6753
- PMC
- PMC5007364
- OpenAlex
- W2518629454
- Cited by
- 110
- References
- 52
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 10 · 2023: 13 · 2022: 19 · 2021: 16 · 2020: 11 · 2019: 15 · 2018: 8 · 2017: 6
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Diabetes Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Basic Research Program of China (2011CB504006, PWZz2013-04, 12030510351)
- Pudong Health and Family Planning Commission of Shanghai (2011CB504006, PWZz2013-04, 12030510351)
- Chinese Medical Association (2011CB504006, PWZz2013-04, 12030510351)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- gut microbiota, sitagliptin, type 2 diabetes, impaired glucose tolerance, obesity, DPP-4 inhibitors, dysbiosis, Firmicutes, Bacteroidetes, short-chain fatty acid-producing bacteria, high-fat high-carbohydrate diet, streptozotocin-induced diabetes, rat model
- MeSH terms
- Sitagliptin Phosphate, Gastrointestinal Microbiome, Animals, Blood Glucose, Body Weight, Hypoglycemic Agents, Glucose Intolerance, Disease Progression, Diabetes Complications, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.